HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by McHenry, C. L. Articles by Thompson, D. A. Search for Related Content PubMed PubMed Citation Articles by McHenry, C. L. Articles by Thompson, D. A.

MERTK Arginine-844-Cysteine in a Patient with Severe Rod–Cone Dystrophy: Loss of Mutant Protein Function in Transfected Cells

¹From the Departments of Ophthalmology and Visual Sciences and ⁵Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan; the ²Department of Genetics, Stanford University School of Medicine, Stanford, California; the ³Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; and the ⁴National Eye Institute, Bethesda, Maryland.

PURPOSE. Mutations in the MERTK gene are responsible for retinal degeneration in the Royal College of Surgeons (RCS) rat and are a cause of human autosomal recessive retinitis pigmentosa (RP). This study reports the identification and functional analysis of novel MERTK mutations to provide information regarding whether they are causative of severe rod–cone degeneration in a young patient.

METHODS. MERTK missense variants identified by single-strand conformational polymorphism (SSCP) and sequence analysis were introduced into expression constructs and used to transfect HEK293T cells. Recombinant protein expression was assayed with anti-MERTK and anti-phosphotyrosine antibodies. Protein turnover was assayed in pulse–chase studies of ³⁵S-methionine incorporation. Transcript levels were determined by quantitative RT-PCR.

RESULTS. Three MERTK sequence variants were identified in a patient with rod–cone dystrophy: R722X in exon 16 and R865W in exon 19 on the paternal allele and R844C in exon 19 on the maternal allele. The R844C sequence change affects an evolutionarily conserved amino acid residue and was not detected in unaffected individuals. In transfected HEK293Tcells, wild-type (wt) and W865 MERTK were expressed at equivalent levels and present in the plasma membrane, stimulated tyrosine phosphorylation, and induced significant rounding of the cell bodies. In contrast, C844 MERTK was expressed at low levels and did not stimulate tyrosine phosphorylation. In addition, the relative stability of C844 MERTK was significantly less than wt in assays of protein turnover. At age 13, the patient had 20/60 and 20/200 acuities, tunnel vision of 5° centrally, and a far temporal peripheral crescent bilaterally, and ERGs were nondetectable. The fundi showed bull’s-eye macular atrophy and widespread RPE thinning.

CONCLUSIONS. The present study reports the identification of R844C, the first putative pathogenic MERTK missense mutation that results in severe retinal degeneration with childhood onset when in compound heterozygous form with a R722X allele. The loss of function of C844 MERTK is probably due to decreased protein stability.

This article has been cited by other articles:

				A. Kazeros, B.-G. Harvey, B. J. Carolan, H. Vanni, A. Krause, and R. G. Crystal Overexpression of Apoptotic Cell Removal Receptor MERTK in Alveolar Macrophages of Cigarette Smokers Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 747 - 757. [Abstract] [Full Text] [PDF]

				A J Brea-Fernandez, E Pomares, M J Brion, G Marfany, M J Blanco, M Sanchez-Salorio, R Gonzalez-Duarte, and A Carracedo Novel splice donor site mutation in MERTK gene associated with retinitis pigmentosa Br. J. Ophthalmol., October 1, 2008; 92(10): 1419 - 1423. [Abstract] [Full Text] [PDF]

				R. H. Henderson, N. Waseem, R. Searle, J. van der Spuy, I. Russell-Eggitt, S. S. Bhattacharya, D. A. Thompson, G. E. Holder, M. E. Cheetham, A. R. Webster, et al. An Assessment of the Apex Microarray Technology in Genotyping Patients with Leber Congenital Amaurosis and Early-Onset Severe Retinal Dystrophy Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5684 - 5689. [Abstract] [Full Text] [PDF]

				H. Tomita, E. Sugano, H. Yawo, T. Ishizuka, H. Isago, S. Narikawa, S. Kugler, and M. Tamai Restoration of Visual Response in Aged Dystrophic RCS Rats Using AAV-Mediated Channelopsin-2 Gene Transfer Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3821 - 3826. [Abstract] [Full Text] [PDF]

				H. S. Cheong, S. O. Lee, C.-B. Choi, Y.-K. Sung, H. D. Shin, and S.-C. Bae MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients Rheumatology, February 1, 2007; 46(2): 209 - 214. [Abstract] [Full Text] [PDF]

				A. Maminishkis, S. Chen, S. Jalickee, T. Banzon, G. Shi, F. E. Wang, T. Ehalt, J. A. Hammer, and S. S. Miller Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3612 - 3624. [Abstract] [Full Text] [PDF]

				M Tschernutter, S A Jenkins, N H Waseem, Z Saihan, G E Holder, A C Bird, S S Bhattacharya, R R Ali, and A R Webster Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene Br. J. Ophthalmol., June 1, 2006; 90(6): 718 - 723. [Abstract] [Full Text] [PDF]

				T. W. Chalberg, H. L. Genise, D. Vollrath, and M. P. Calos {phi}C31 Integrase Confers Genomic Integration and Long-Term Transgene Expression in Rat Retina Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2140 - 2146. [Abstract] [Full Text] [PDF]